![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Iris Goetz, Casey Choong, Jennifer Winnie, David R. Nelson, Julie Birt, Virginia Noxon, Helen Varker, Nicole Zimmerman & Joseph Tkacz. (2022) Development of a claims-based flare algorithm for systemic lupus erythematosus. Current Medical Research and Opinion 38:9, pages 1641-1649.
Read now
Read now
Shuangjun He, Jun Ma, Chenyu Fan, Chao Tang, Yi Chen & Cuiying Xie. (2021) Performance of Procalcitonin to Distinguish Fungal from Bacterial Infections in Patients with Systemic Lupus Erythematosus. Infection and Drug Resistance 14, pages 4773-4781.
Read now
Read now
Celine Miyazaki, Rosarin Sruamsiri, Jörg Mahlich & Wonjoo Jung. (2020) Treatment patterns and medical cost of systemic lupus erythematosus patients in Japan: a retrospective claims database study. Journal of Medical Economics 23:7, pages 786-799.
Read now
Read now
Le Zhang, Guo Hong Lu, Shuang Ye, Bin Wu, Yi Shen & Ting Li. (2017) Treatment adherence and disease burden of individuals with rheumatic diseases admitted as outpatients to a large rheumatology center in Shanghai, China. Patient Preference and Adherence 11, pages 1591-1601.
Read now
Read now
Bingcao Wu, Gaurav Deshpande, Tao Gu, Breanna Popelar, Michael Philbin & George J. Wan. (2017) Demographics, treatment patterns, and healthcare utilization and cost of repository corticotropin injection in patients with systemic lupus erythematosus or rheumatoid arthritis. Journal of Medical Economics 20:11, pages 1170-1177.
Read now
Read now
Articles from other publishers (65)
Soo-Kyung Cho, Hyoungyoung Kim, Jung-Yong Han, Yena Jeon, Sun-Young Jung, Eun Jin Jang & Yoon-Kyoung Sung. (2023) Risk of end-stage renal disease in patients with early-onset lupus nephritis: A population-based cohort study. Seminars in Arthritis and Rheumatism 63, pages 152308.
Crossref
Crossref
Adrian Paul J Rabe, Wei Jie Loke, Rubana N Kalyani, Raj Tummala, Heide A Stirnadel-Farrant, John Were & Kevin L Winthrop. (2023) Impact of SARS-CoV-2 infection on patients with systemic lupus erythematosus in England prior to vaccination: a retrospective observational cohort study. BMJ Open 13:11, pages e071072.
Crossref
Crossref
Emma Materne, Hyon Choi, Baijun Zhou, Karen H. Costenbader, Yuqing Zhang & April Jorge. (2023) Comparative Risks of Infection With Belimumab Versus Oral Immunosuppressants in Patients With Nonrenal Systemic Lupus Erythematosus. Arthritis & Rheumatology 75:11, pages 1994-2002.
Crossref
Crossref
Heide A. Stirnadel-Farrant, Sarowar M. Golam, Barbara Naisbett-Groet, Danny Gibson, Julia Langham, Sue Langham & Mihail Samnaliev. (2023) Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK. Rheumatology and Therapy 10:5, pages 1183-1197.
Crossref
Crossref
Sandra Sze-jung WuAllison PerryJoseph TkaczGary Bryant. (2023) Clinical and economic characterization of mild, moderate, and severe systemic lupus erythematosus: Real-world observation across payer channels in the United States. Journal of Managed Care & Specialty Pharmacy 29:9, pages 1010-1020.
Crossref
Crossref
Sarah B Lieber, Musarrat Nahid, Iris Navarro-Millán, Mangala Rajan, Sebastian E Sattui & Lisa A Mandl. (2023) Frailty and emergency department utilisation in adults with systemic lupus erythematosus ≤65 years of age: an administrative claims data analysis of Medicaid beneficiaries. Lupus Science & Medicine 10:2, pages e000905.
Crossref
Crossref
Shirley P. Huang, Maral DerSarkissian, Yuqian M. Gu, Mei Sheng Duh, Min-Jung Wang, John Benson, Jensen Duy Vu, Carlyne M. Averell & Christopher F. Bell. (2023) Health Care Costs With Sustained Oral Corticosteroid Use in Systemic Lupus Erythematosus. Clinical Therapeutics 45:7, pages 619-626.
Crossref
Crossref
Shirley P. Huang, Amy Guisinger, Carlyne Averell, Christopher F. Bell & Bernie Rubin. (2023) Clinical and Economic Burden of Systemic Lupus Erythematosus in the Years Preceding End-Stage Kidney Disease Diagnosis: A Retrospective Observational Study. Rheumatology and Therapy 10:3, pages 551-562.
Crossref
Crossref
Maral DerSarkissian, Yuqian M. Gu, Mei Sheng Duh, John Benson, Shirley P. Huang, Carlyne Averell, Jensen Vu, Min‐Jung Wang & Christopher F. Bell. (2023)
Clinical and Economic Burden in Patients With Systemic Lupus Erythematosus During the First Year After Initiating Oral Corticosteroids: A Retrospective
US
Database Study
. ACR Open Rheumatology 5:6, pages 318-328.
Crossref
Crossref
Meghan Corrigan Nelson, Colleen Mosley, D Sofia Villacis-Nunez, Kelly Rouster-Stevens & Amit Thakral. (2023) Impact of follow-up adherence on disease activity in childhood-onset systemic lupus erythematosus (cSLE). Lupus 32:6, pages 799-803.
Crossref
Crossref
Christopher F Bell, Benjamin Wu, Shirley P Huang, Bernard Rubin, Carlyne M Averell, Benjamin Chastek, Erin M Hulbert & Joan Von Feldt. (2023) Healthcare Resource Utilization and Associated Costs in Patients With Systemic Lupus Erythematosus Diagnosed With Lupus Nephritis. Cureus.
Crossref
Crossref
Shirley P HuangMaral DerSarkissianYuqian M GuMei Sheng DuhMin-Jung WangJohn BensonJensen VuCarlyne AverellChristopher F Bell. (2023) Prolonged oral corticosteroid treatment in patients with systemic lupus erythematosus: An evaluation of 12-month economic and clinical burden. Journal of Managed Care & Specialty Pharmacy 29:4, pages 365-377.
Crossref
Crossref
Sebastian Bruera, Xiudong Lei, Xerxes Pundole, Hui Zhao, Sharon H. Giordano, Surabhi Vinod & Maria E. Suarez‐Almazor. (2022) Systemic Lupus Erythematosus and Mortality in Elderly Patients With Early Breast Cancer. Arthritis Care & Research 75:3, pages 559-568.
Crossref
Crossref
Christopher F Bell, Shirley P Huang, Anissa Cyhaniuk & Carlyne M Averell. (2022) The cost of flares among patients with systemic lupus erythematosus with and without lupus nephritis in the United States. Lupus 32:2, pages 301-309.
Crossref
Crossref
Mia T. Chandler, Leah M. Santacroce, Karen H. Costenbader, Seoyoung C. Kim & Candace H. Feldman. (2023) Racial differences in persistent glucocorticoid use patterns among medicaid beneficiaries with incident systemic lupus erythematosus. Seminars in Arthritis and Rheumatism 58, pages 152122.
Crossref
Crossref
Katja Bieber, Jennifer E. Hundt, Xinhua Yu, Marc Ehlers, Frank Petersen, Christian M. Karsten, Jörg Köhl, Khalaf Kridin, Kathrin Kalies, Anika Kasprick, Stephanie Goletz, Jens Y. Humrich, Rudolf A. Manz, Axel Künstner, Christoph M. Hammers, Reza Akbarzadeh, Hauke Busch, Christian D. Sadik, Tanja Lange, Hanna Grasshoff, Alexander M. Hackel, Jeanette Erdmann, Inke König, Walter Raasch, Mareike Becker, Anja Kerstein-Stähle, Peter Lamprecht, Gabriela Riemekasten, Enno Schmidt & Ralf J. Ludwig. (2023) Autoimmune pre-disease. Autoimmunity Reviews 22:2, pages 103236.
Crossref
Crossref
Baptiste Chevet, Gabriel Figueroa-Parra, Maria O. Valenzuela-Almada, Mehmet Hocaoglu, Sebastian Vallejo, Shirley-Ann Osei-Onomah, Rachel E. Giblon, Jesse Y. Dabit, Alanna M. Chamberlain, Divi Cornec, Kurt J. Greenlund, Kamil E. Barbour, Cynthia S. Crowson & Alí Duarte-García. (2023) Health Care Utilization in Systemic Lupus Erythematosus in the Community. JCR: Journal of Clinical Rheumatology 29:1, pages 29-35.
Crossref
Crossref
Yiting Wang, Laura L. Hester, Jennifer Lofland, Shawn Rose, Chetan S. Karyekar, David M. Kern, Margaret Blacketer, Kourtney Davis & Kimberly Shields-Tuttle. (2022) Update on prevalence of diagnosed systemic lupus erythematosus (SLE) by major health insurance types in the US in 2016. BMC Research Notes 15:1.
Crossref
Crossref
Salena Marie Preciado, Khaled A. Elsaid, Souhiela Fawaz, Lawrence Brown, Enrique Seoane-Vazquez, Marc Fleming & Yun Wang. (2022) Exploratory Analysis of Outpatient Visits for US Adults Diagnosed with Lupus Erythematosus: Findings from the National Ambulatory Medical Care Survey 2006–2016. Healthcare 10:9, pages 1664.
Crossref
Crossref
Dora H Lin, Irene B Murimi-Worstell, Hong Kan, Jonothan C Tierce, Xia Wang, Henk Nab, Barnabas Desta, Edward R Hammond & G Caleb Alexander. (2022) Health care utilization and costs of systemic lupus erythematosus in the United States: A systematic review. Lupus 31:7, pages 773-807.
Crossref
Crossref
Sebastian Bruera, Xiudong Lei, Brandon Blau, Hui Zhao, Anita Deswal, Jinoos Yazdany, Sharon H. Giordano & Maria E. Suarez‐Almazor. (2022) Postoperative Major Adverse Cardiac Events in Patients With Systemic Lupus Erythematosus. ACR Open Rheumatology 4:6, pages 511-519.
Crossref
Crossref
Shannon Grabich, Eileen Farrelly, Robert Ortmann, Michael Pollack & Sandra Sze-jung Wu. (2022) Real-world burden of systemic lupus erythematosus in the USA: a comparative cohort study from the Medical Expenditure Panel Survey (MEPS) 2016–2018. Lupus Science & Medicine 9:1, pages e000640.
Crossref
Crossref
Christopher F Bell, Mayank R Ajmera & Juliana Meyers. (2022) An evaluation of costs associated with overall organ damage in patients with systemic lupus erythematosus in the United States. Lupus 31:2, pages 202-211.
Crossref
Crossref
Juliette C. Thompson, Anadi Mahajan, David A. Scott & Kerry Gairy. (2021) The Economic Burden of Lupus Nephritis: A Systematic Literature Review. Rheumatology and Therapy 9:1, pages 25-47.
Crossref
Crossref
Hawraa Kadhim Abbas, Dheyaa Jabbar Kadhim, Faiq Isho Gorial & Laith G. Shareef. (2022) Assessment of medication-related burden among a sample of Iraqi patients with systemic lupus erythematosus and its relationship with disease activity: a cross-sectional study. F1000Research 11, pages 970.
Crossref
Crossref
Hawraa Kadhim Abbas, Dheyaa Jabbar Kadhim, Faiq Isho Gorial & Laith G. Shareef. (2022) Assessment of medication-related burden among a sample of Iraqi patients with systemic lupus erythematosus and its relationship with disease activity: a cross-sectional study. F1000Research 11, pages 970.
Crossref
Crossref
Edward R Hammond, Barnabas Desta, Aimee M Near, Xia Wang & Miao Jiang. (2021) Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004–2015. Lupus Science & Medicine 8:1, pages e000504.
Crossref
Crossref
Miao Jiang, Aimee M Near, Barnabas Desta, Xia Wang & Edward R Hammond. (2021) Disease and economic burden increase with systemic lupus erythematosus severity 1 year before and after diagnosis: a real-world cohort study, United States, 2004–2015. Lupus Science & Medicine 8:1, pages e000503.
Crossref
Crossref
Mihail Samnaliev, Volkan Barut, Sharada Weir, Julia Langham, Sue Langham, Xia Wang, Barnabas Desta & Edward Hammond. (2021) Health-care utilization and costs in adults with systemic lupus erythematosus in the United Kingdom: a real-world observational retrospective cohort analysis. Rheumatology Advances in Practice 5:3.
Crossref
Crossref
Julia Langham, Volkan Barut, Mihail Samnaliev, Sue Langham, Sharada Weir, Xia Wang, Barnabas Desta & Edward Hammond. (2021) Disease severity, flares and treatment patterns in adults with systemic lupus erythematosus in the UK: a real-world observational retrospective cohort analysis. Rheumatology Advances in Practice 5:3.
Crossref
Crossref
Tasneem Lokhandwala, Anna D. Coutinho & Christopher F. Bell. (2021) Retrospective Analysis of Disease Severity, Health Care Resource Utilization, and Costs Among Patients Initiating Belimumab for the Treatment of Systemic Lupus Erythematosus. Clinical Therapeutics 43:8, pages 1320-1335.
Crossref
Crossref
Pedro Alves, Jigar Bandaria, Michelle B Leavy, Benjamin Gliklich, Costas Boussios, Zhaohui Su & Gary Curhan. (2021) Validation of a machine learning approach to estimate Systemic Lupus Erythematosus Disease Activity Index score categories and application in a real-world dataset. RMD Open 7:2, pages e001586.
Crossref
Crossref
Rachel L Randell, Lindsay Singler, Anthony Cunningham, Laura E Schanberg, Michael Cohen-Wolkowiez, Christoph P Hornik & Stephen J Balevic. (2021) Delivering clinical trials at home: protocol, design and implementation of a direct-to-family paediatric lupus trial. Lupus Science & Medicine 8:1, pages e000494.
Crossref
Crossref
Ashley A White, Aissatou Ba, Trevor Daniel Faith, Viswanathan Ramakrishnan, Clara L Dismuke-Greer, Jim C Oates & Edith Marie Williams. (2021) The Care-coordination Approach to Learning Lupus Self-Management: a patient navigator intervention for systemic lupus inpatients. Lupus Science & Medicine 8:1, pages e000482.
Crossref
Crossref
Irene B. Murimi-Worstell, Dora H. Lin, Hong Kan, Jonothan Tierce, Xia Wang, Henk Nab, Barnabas Desta, G. Caleb Alexander & Edward R. Hammond. (2021) Healthcare Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States. The Journal of Rheumatology 48:3, pages 385-393.
Crossref
Crossref
Andreas Schwarting, Heiko Friedel, Elena Garal-Pantaler, Marc Pignot, Xia Wang, Henk Nab, Barnabas Desta & Edward R. Hammond. (2021) The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization. Rheumatology and Therapy 8:1, pages 375-393.
Crossref
Crossref
Tasneem Lokhandwala, Binglin Yue, Anna D Coutinho & Christopher F Bell. (2021) Within-trial economic analysis of flare data from the BLISS-SC trial of subcutaneous belimumab in systemic lupus erythematosus. Lupus Science & Medicine 8:1, pages e000438.
Crossref
Crossref
Christopher F. Bell, Matthew Lau, Melody Lee & Christine Poulos. (2020) Insights into the choice between intravenous infusion and subcutaneous injection: physician and patient characteristics driving treatment in SLE. Clinical Rheumatology 40:2, pages 581-590.
Crossref
Crossref
Johanna Callhoff, Hannes Jacobs, Katinka Albrecht, Joachim Saam, Angela Zink & Falk Hoffmann. (2020) Factors Associated with Survey Non-Response in a Cross-Sectional Survey of Persons with an Axial Spondyloarthritis or Osteoarthritis Claims Diagnosis. International Journal of Environmental Research and Public Health 17:24, pages 9186.
Crossref
Crossref
Candace H. Feldman, Chang Xu, Jessica Williams, Jamie E. Collins & Karen H. Costenbader. (2020) Patterns and predictors of recurrent acute care use among Medicaid beneficiaries with systemic lupus erythematosus. Seminars in Arthritis and Rheumatism 50:6, pages 1428-1436.
Crossref
Crossref
Ann E. Clarke, Arthur Weinstein, Andrew Piscitello, Avneet Heer, Tarun Chandra, Shivang Doshi, John Wegener, Thomas F. Goss & Tami Powell. (2020) Evaluation of the Economic Benefit of Earlier Systemic Lupus Erythematosus (SLE) Diagnosis Using a Multivariate Assay Panel (MAP). ACR Open Rheumatology 2:11, pages 629-639.
Crossref
Crossref
Ann E. Clarke, Jinoos Yazdany, Shaum M. Kabadi, Emily Durden, Isabelle Winer, Kirstin Griffing & Karen H. Costenbader. (2020) The economic burden of systemic lupus erythematosus in commercially- and medicaid-insured populations in the United States. Seminars in Arthritis and Rheumatism 50:4, pages 759-768.
Crossref
Crossref
Christopher F Bell, Julie Priest, Marni Stott-Miller, Hong Kan, Justyna Amelio, Xue Song, Brendan Limone, Virginia Noxon & Karen H Costenbader. (2020) Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA. Lupus Science & Medicine 7:1, pages e000357.
Crossref
Crossref
Daniel Li, Kazuki Yoshida, Candace H Feldman, Cameron Speyer, Medha Barbhaiya, Hongshu Guan, Daniel H Solomon, Brendan M Everett & Karen H Costenbader. (2020) Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus. Rheumatology 59:3, pages 495-504.
Crossref
Crossref
Cameron B. Speyer, Daniel Li, Hongshu Guan, Kazuki Yoshida, Emma Stevens, April M. Jorge, Brendan M. Everett, Candace H. Feldman & Karen H. Costenbader. (2019) Comparison of an administrative algorithm for SLE disease severity to clinical SLE Disease Activity Index scores. Rheumatology International 40:2, pages 257-261.
Crossref
Crossref
Le Zhang, Wei Luan, Shikai Geng, Shuang Ye, Xiaodong Wang, Liping Qian, Yang Ding, Ting Li & Anli Jiang. (2019) Lack of patient education is risk factor of disease flare in patients with systemic lupus erythematosus in China. BMC Health Services Research 19:1.
Crossref
Crossref
Jiha Lee, Judith Lin, Lisa Gale Suter & Liana Fraenkel. (2019) Persistently Frequent Emergency Department Utilization Among Persons With Systemic Lupus Erythematosus. Arthritis Care & Research 71:11, pages 1410-1418.
Crossref
Crossref
S Kabadi, J Yeaw, A K Bacani, E Tafesse, K Bos, S Karkare, M DeKoven & E R Vina. (2018) Healthcare resource utilization and costs associated with long-term corticosteroid exposure in patients with systemic lupus erythematosus. Lupus 27:11, pages 1799-1809.
Crossref
Crossref
Yoshiya Tanaka, Akiko Mizukami, Akihiro Kobayashi, Chie Ito & Taizo Matsuki. (2018) Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: A retrospective, observational study. International Journal of Rheumatic Diseases 21:8, pages 1609-1618.
Crossref
Crossref
Edith M. Williams, Rebekah J. Walker, Trevor Faith & Leonard E. Egede. (2017) The impact of arthritis and joint pain on individual healthcare expenditures: findings from the Medical Expenditure Panel Survey (MEPS), 2011. Arthritis Research & Therapy 19:1.
Crossref
Crossref
Edith M. Williams, Leonard Egede, Trevor Faith & James Oates. (2017) Effective Self-Management Interventions for Patients With Lupus: Potential Impact of Peer Mentoring. The American Journal of the Medical Sciences 353:6, pages 580-592.
Crossref
Crossref
Y. M. Chiu, M. T. Chuang & H. C. Lang. (2016) Medical costs incurred by organ damage caused by active disease, comorbidities and side effect of treatments in systemic lupus erythematosus patients: a Taiwan nationwide population-based study. Rheumatology International 36:11, pages 1507-1514.
Crossref
Crossref
Erin E. Carter, Susan G. Barr & Ann E. Clarke. (2016) The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nature Reviews Rheumatology 12:10, pages 605-620.
Crossref
Crossref
John G. Hanly, Kara Thompson & Chris Skedgel. (2016) Utilization of Ambulatory Physician Encounters, Emergency Room Visits, and Hospitalizations by Systemic Lupus Erythematosus Patients: A 13-Year Population Health Study. Arthritis Care & Research 68:8, pages 1128-1134.
Crossref
Crossref
M Y Choi, M R W Barber, C E H Barber, A E Clarke & M J Fritzler. (2016) Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care. Lupus 25:8, pages 838-849.
Crossref
Crossref
Andreas Jönsen, Frida Hjalte, Minna Willim, Katarina Steen Carlsson, Christopher Sjöwall, Elisabet Svenungsson, Dag Leonard, Christine Bengtsson, Solbritt Rantapää- Dahlqvist, Susanne Pettersson, Iva Gunnarsson, Agneta Zickert, Johanna T. Gustafsson, Lars Rönnblom, Ingemar F. Petersson, Anders A. Bengtsson & Ola Nived. (2016) Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts. Seminars in Arthritis and Rheumatism 45:6, pages 684-690.
Crossref
Crossref
Hong Kan, Saurabh Nagar, Jeetvan Patel, Daniel J. Wallace, Charles Molta & David J. Chang. (2016) Longitudinal Treatment Patterns and Associated Outcomes in Patients With Newly Diagnosed Systemic Lupus Erythematosus. Clinical Therapeutics 38:3, pages 610-624.
Crossref
Crossref
Cindy Garris, Manan Shah & Eileen Farrelly. (2015) The prevalence and burden of systemic lupus erythematosus in a medicare population: retrospective analysis of medicare claims. Cost Effectiveness and Resource Allocation 13:1.
Crossref
Crossref
Xuehua Ke, Debra F. Eisenberg Lawrence, Alan Oglesby, Jeetvan Patel, Hong Kan & Robert Boggs. (2015) A Retrospective Administrative Claims Database Evaluation of the Utilization of Belimumab in US Managed Care Settings. Clinical Therapeutics 37:12, pages 2852-2863.
Crossref
Crossref
Lihua Shi, Zhe Zhang, Li Song, Yiu Tak Leung, Michelle A Petri & Kathleen E Sullivan. (2015) Monocyte enhancers are highly altered in systemic lupus erythematosus. Epigenomics 7:6, pages 921-935.
Crossref
Crossref
Shih-Yin Chen, Chan-Bum Choi, Qian Li, Wei-Shi Yeh, Yuan-Chi Lee, Amy H. Kao & Matthew H. Liang. (2015) Glucocorticoid Use in Patients With Systemic Lupus Erythematosus: Association Between Dose and Health Care Utilization and Costs. Arthritis Care & Research 67:8, pages 1086-1094.
Crossref
Crossref
Elizabeth Stringer & Sasha Bernatsky. (2014) Validity of juvenile idiopathic arthritis diagnoses using administrative health data. Rheumatology International 35:3, pages 575-579.
Crossref
Crossref
Ann E. Clarke, Murray B. Urowitz, Neerav Monga & John G. Hanly. (2015) Costs Associated With Severe and Nonsevere Systemic Lupus Erythematosus in Canada. Arthritis Care & Research 67:3, pages 431-436.
Crossref
Crossref
Corey Casper, Dana Y. Teltsch, Don RobinsonJrJr, Marie-Pierre Desrosiers, Philip Rotella, Angela Dispenzieri, Ming Qi, Thomas Habermann & Matthew W. Reynolds. (2015) Clinical characteristics and healthcare utilization of patients with multicentric Castleman disease. British Journal of Haematology 168:1, pages 82-93.
Crossref
Crossref
Marvin J Fritzler. (2014) Perspectives on the imperatives, opportunities and challenges for point-of-care diagnostics in systemic lupus erythematosus. International Journal of Clinical Rheumatology 9:5, pages 449-456.
Crossref
Crossref